代谢综合征与备孕时间:一项无产次女性的回顾性研究
该多中心回顾性队列研究纳入5519名低危无产次孕妇,于孕14–16周采集血样并按国际糖尿病联盟标准判定代谢综合征。结果显示,代谢综合征与更长的备孕时间及不孕风险相关,且该关联不依赖于肥胖。
要点
- 代谢综合征孕妇的调整时间比为1.30,备孕时间更长。
- 代谢综合征孕妇不孕风险增加62%,肥胖与非肥胖者均如此。
- 低高密度脂蛋白胆固醇和高甘油三酯是与不孕风险相关的主要单一组分。
核心结论
- 代谢综合征与更长的备孕时间和不孕相关,且不依赖于肥胖。
研究设计与样本
- 多中心(澳大利亚、爱尔兰、新西兰和英国)回顾性队列研究,纳入5519名低危无产次孕妇。
- 于孕14–16周采集血样评估代谢健康,代谢综合征按国际糖尿病联盟标准定义。
- 采用对数正态分布的加速失效时间模型估计时间比(TR)及95%CI,采用泊松分布的广义线性模型比较不孕(备孕时间>12个月)的相对风险(RR)及95%CI。
- 全部分析(全队列及按体重指数分层)均控制了多种母方和父方混杂因素。
主要发现
- 5519名女性中12.4%(n=684)患有代谢综合征。
- 与无代谢综合征的女性相比,代谢综合征女性的调整时间比为1.30(95%CI 1.15–1.46),在肥胖和非肥胖女性中相似。
- 代谢综合征女性与无代谢综合征女性的中位备孕时间边际估计分别为4.1个月(95%CI 3.6–4.5个月)和3.1个月(95%CI 3.0–3.3个月)。
- 代谢综合征女性不孕风险增加62%;肥胖者调整RR为1.62(95%CI 1.15–2.29),非肥胖者调整RR为1.73(95%CI 1.33–2.23)。
- 低高密度脂蛋白胆固醇(HDL-C)和高甘油三酯(TGs)是与不孕风险相关的主要单一组分。
局限性
- 作者结论指出,需要孕前开展更多研究来支持本研究发现,并确定哪些代谢异常组合对生育延迟风险最大,或单一组分是否可被干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine: (1) the association between metabolic syndrome (MetS), time to pregnancy (TTP), and infertility; (2) associations between individual and an increasing number of MetS components, TTP, and infertility; and (3) whether these relationships differ by body mass index (BMI < 30 kg/m2 versus BMI ≥ 30 kg/m2 ). DESIGN: Retrospective cohort study. SETTING: Multiple centres (in Australia, Ireland, New Zealand, and the UK). POPULATION: Five thousand five hundred and nineteen low-risk nulliparous pregnant women. METHODS: Data on retrospectively reported TTP (number of months to conceive) and a blood sample to assess metabolic health were collected between 14 and 16 weeks of gestation. MetS was defined according to the International Diabetes Federation criteria. Accelerated failure time models with log-normal distribution were conducted to estimate time ratios (TRs) and 95% CIs. Differences in MetS on infertility (TTP > 12 months) were compared using a generalised linear model (Poisson distribution) with robust variance estimates (relative risks, RRs; 95% CIs). All analyses (entire cohort and split by BMI) were controlled for a range of maternal and paternal confounding factors. MAIN OUTCOME MEASURES: Time to pregnancy and infertility. RESULTS: Of the 5519 women included, 12.4% (n = 684) had MetS. Compared with women without MetS, women with MetS had a longer TTP (adjusted TR 1.30; 95% CI 1.15-1.46), which was similar in women who were obese and in women who were not obese. Marginal estimates for median TTP in women with MetS versus without MetS was 3.1 months (3.0-3.3 months) versus 4.1 months (3.6-4.5 months), respectively. Women with MetS were at a 62% greater risk for infertility and were at a greater risk for infertility whether they were obese (adjusted RR 1.62; 95% CI 1.15-2.29) or not (adjusted RR 1.73; 95% CI 1.33-2.23). Reduced high-density lipoprotein cholesterol (HDL-C) and raised triglycerides (TGs) were the main individual components associated with risk for infertility. CONCLUSION: Metabolic syndrome is associated with longer TTP and infertility, independent of obesity. Additional studies, before pregnancy, are required to support our findings and to determine the applicability of which combinations of metabolic abnormalities pose the greatest risk to delayed fertility, or whether individual components are amenable to modification. TWEETABLE ABSTRACT: Metabolic syndrome is associated with longer time to pregnancy and infertility, independent of obesity.
引用
- Grieger JA, Grzeskowiak LE, Smithers LG, et al. Metabolic syndrome and time to pregnancy: a retrospective study of nulliparous women. BJOG. 2019. PMID: 30734474. doi:10.1111/1471-0528.15647
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。